Invesco
WHCE.L
IE000L4EH2K5
Invesco S&P World Health Care ESG UCITS ETF Acc
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
30.93
Weighted Fwd P/E
17.62
Avg P/FCF
26.88
Avg FCF Yield
3.60%
Avg EV / EBITDA
16.8
Avg EV / Revenue
6.62
Avg Price-to-Book (P/B)
52.39
Avg Price-to-Sales (P/S)
6.12
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
-43.03%
Avg Debt-to-Equity (D/E)
204.02%
<50% (10.72%) 50-150% (47.5%) >150% (29.28%) Unreported (12.49%)

Profitability Analysis

75 Holdings Count
Profitable 98.93%
Profitable 98.93%
73 Holdings Count (97.33%)
Unprofitable 1.07%
2 Holdings Count (2.67%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

High Concentration (Top-Heavy)
Top 5
43.9%
Top 10
63.5%
Top 25
85.6%
50% Threshold
Top 7
The top 10 holdings account for 63.5% of the total ETF. Performance is heavily driven by a few heavyweights. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

16 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (17.5%+)
High (45.4%+)
Top (62.9%+)

Country Breakdown

Max: 69.85%
US US US
69.85%
CH CH CH
10.61%
GB GB GB
5.55%
JP JP JP
4.27%
IE IE IE
2.50%
FR FR FR
1.95%
DE DE DE
1.21%
AU AU AU
1.20%
NL NL NL
0.70%
IL IL IL
0.52%
BE BE BE
0.50%
DK DK DK
0.48%
NZ NZ NZ
0.23%
SE SE SE
0.21%
FI FI FI
0.12%
IT IT IT
0.09%

Sector Distribution

1 Sector
Healthcare
100.00%

Industry Distribution

8 Industries
Drug Manufacturers - General
65.66%
Medical Devices
11.21%
Diagnostics & Research
9.06%
Biotechnology
4.01%
Medical Instruments & Supplies
3.54%
Drug Manufacturers - Specialty & Generic
3.15%
Healthcare Plans
2.92%
Medical Care Facilities
0.45%

Market Cap Distribution

75 Holdings Count
Mega Cap (> 200B)
(10) 57.33%
Large Cap (10B - 200B)
(57) 41.87%
Mid Cap (2B - 10B)
(8) 0.80%
ende